Skip to main content

Table 2 Participant Reproductive Health Information

From: Medical abortion in Nepal: a qualitative study on women’s experiences at safe abortion services and pharmacies

 

Clinic Clients

(n = 10)

Pharmacy Clients

(n = 10)

ALL Participants

(n = 20)

MA use prior to interview#

  < 3 months

0

2

2

 3–6 months

10

2

12

 6 months – 1 year

0

1

1

 1–2 years

0

3

3

 2–3 years

0

2

2

Incomplete abortion after MA use

 Yes

1

3

4

 No

9

7

16

Contraceptive use directly prior to MA

 Yes

3

1

4

  OCPa

1

0

1

  Intermittent OCP

1

1

1

  Intermittent Injectableb

1

0

1

 No

7

9

16

  No- wanted to conceive*

1

0

1

Contraceptive use directly after MA

 Yes

10

2

12

  Condoms

1

0

1

  OCP

5

0

5

  Injectable (Depobb)

0

1

1

  Implantc (Norplantcc)

4

0

4

  IUDd (Copper Tdd)

0

1+

1

 No

0

8

8

Current contraceptive use

 Yes

8

3

11

  Condoms

1

0

1

  Intermittent OCP

2

0

1

  OCP

1

0

2

  Depo

0

1

1

  Norplant

4

1

5

  Copper T

0

1

1

 No

2

7

9

  No - wants to conceive ^

0

1

1

Previous abortion/s

 None

8

9

17

 One

1

1

2

 Two

1

0

1

Previous miscarriage/s

 None

6

10

16

 One

4

0

4

Number of deceased children

  

 None

10

8

18

 One

0

1

1

 Two

0

1

1

Number of living children

 One

4

2

6

 Two

5

6

11

 Three

0

1

1

 Four

1

1

2

Child/children sex-mix

 Female and Male

3

5

8

 Only Female

4

3

7

 Only Male

3

2

5

Age when married

 Under 18 years

2

2

4

 18–20 years

4

5

9

 21–23 years

4

0

4

 24–26 years

0

1

1

 Not Recorded

0

2

2

Age at birth of first child

 Under 18 years

1

1

2

 18–20 years

3

4

7

 21–23 years

4

2

6

 24–26 years

2

1

3

 Not Recorded

0

2

2

  1. # Approximate timeframe between the participant taking MA and their in-depth interview
  2. a Oral Contraceptive Pill
  3. b Hormonal contraceptive injection
  4. bb Hormonal contraceptive injection brand
  5. c Hormonal contraceptive implant
  6. cc Hormonal contraceptive implant brand
  7. d Intrauterine Device
  8. dd Non-hormonal intrauterine device
  9. * The total count for participants not using contraception when they fell pregnant before their subsequent MA includes one participant who was not using contraception as she wanted to become pregnant at that time
  10. + Contraceptive method was not obtained through a pharmacy. Method was inserted at an SRH Clinic shortly after taking MA
  11. ^ The total count for participants currently not using contraception includes one participant who is not currently using contraception as they want to become pregnant